E-LIB Suche - Ergebnisse für: Krepler, Clemens

1

Pembrolizumab versus placebo as adjuvant therapy in resecte..:

Schadendorf, Dirk ; Luke, Jason John ; Ascierto, Paolo A...
Journal for ImmunoTherapy of Cancer. 12 (2024) 3 - p. e007501 , 2024

Link: https://doi.org/10.1136/..

2

Safety of pembrolizumab as adjuvant therapy in a pooled ana..:

Luke, Jason J. ; Long, Georgina V. ; Robert, Caroline...
European Journal of Cancer. 207 (2024) - p. 114146 , 2024

Link: https://doi.org/10.1016/..

3

Cost-Effectiveness Analysis of Pembrolizumab as an Adjuvant..:

Zhang, Shujing ; Bensimon, Arielle G. ; Xu, Ruifeng...
Advances in Therapy. 40 (2023) 7 - p. 3038-3055 , 2023

Link: https://doi.org/10.1007/..

4

A distinct pattern of growth and RAC1 signaling in melanoma..:

Stejerean-Todoran, Ioana ; Gimotty, Phyllis A ; Watters, Andrea...
Neuro-Oncology. 25 (2022) 4 - p. 674-686 , 2022

Link: https://doi.org/10.1093/..

5

Persister state-directed transitioning and vulnerability in..:

Chauvistré, Heike ; Shannan, Batool ; Daignault-Mill, Sheena M....
Nature Communications. 13 (2022) 1 - p. , 2022

Link: https://doi.org/10.1038/..

6

Adjuvant pembrolizumab versus placebo in resected high-risk..:

Khattak, Muhammad A. ; Luke, Jason J. ; Long, Georgina V....
European Journal of Cancer. 176 (2022) - p. 207-217 , 2022

Link: https://doi.org/10.1016/..

7

Baseline and post-treatment biomarkers of resistance to ant..:

Shui, Irene M. ; Liu, Xiao Qiao ; Zhao, Qing...
Journal for ImmunoTherapy of Cancer. 10 (2022) 7 - p. e004879 , 2022

Link: https://doi.org/10.1136/..

8

Real-World Therapy with Pembrolizumab: Outcomes and Surroga..:

Mohr, Peter ; Scherrer, Emilie ; Assaf, Chalid...
Cancers. 14 (2022) 7 - p. 1804 , 2022

Link: https://doi.org/10.3390/..

9

Real-world Clinical Outcomes of Patients with Stage IIB or ..:

Samlowski, Wolfram ; Silver, Michelle A ; Hohlbauch, Andriana...
Future Oncology. 18 (2022) 33 - p. 3755-3767 , 2022

Link: https://doi.org/10.2217/..

10

Neural Crest-Like Stem Cell Transcriptome Analysis Identifi..:

Liu, Jianglan ; Rebecca, Vito W. ; Kossenkov, Andrew V....
Cancer Research. 81 (2021) 20 - p. 5230-5241 , 2021

Link: https://doi.org/10.1158/..

11

Tumor-infiltrating mast cells are associated with resistanc..:

Somasundaram, Rajasekharan ; Connelly, Thomas ; Choi, Robin...
Nature Communications. 12 (2021) 1 - p. , 2021

Link: https://doi.org/10.1038/..

12

Crossover and rechallenge with pembrolizumab in recurrent p..:

Eggermont, Alexander MM. ; Meshcheryakov, Andrey ; Atkinson, Victoria...
European Journal of Cancer. 158 (2021) - p. 156-168 , 2021

Link: https://doi.org/10.1016/..

13

Inhibition of endothelin-B receptor signaling synergizes wi..:

Schäfer, Alexander ; Haenig, Benedicte ; Erupathil, Julie...
Oncogene. 40 (2021) 9 - p. 1659-1673 , 2021

Link: https://doi.org/10.1038/..

14

An Economic Evaluation of Pembrolizumab Versus Other Adjuva..:

Bensimon, Arielle G. ; Zhou, Zheng-Yi ; Jenkins, Madeline...
Clinical Drug Investigation. 40 (2020) 7 - p. 629-643 , 2020

Link: https://doi.org/10.1007/..

15

An observational study of drug utilization and associated o..:

Cowey, Charles L. ; Boyd, Marley ; Aguilar, Kathleen M....
Cancer Medicine. 9 (2020) 21 - p. 7863-7878 , 2020

Link: https://doi.org/10.1002/..